Abstract:Purpose Understanding the interplay between transparency, accountability and e-procurement and their collective contribution to anti-corruption efforts in public procurement is crucial for developing effective strategies and policies. This research seeks to investigate whether e-procurement plays a significant role in enhancing transparency and accountability and subsequently reducing corruption risks in the public pharmaceutical procurement system. Design/methodology/approach The study employed a cross-sectional questionnaire survey to gather data from 274 procurement personnel and pharmacists working in 28 government-owned hospitals in the Southern Highlands of Tanzania. The collected data were then analysed using confirmatory factor analysis (CFA) and the Hayes PROCESS macro to test the study hypotheses. Findings The study findings revealed a negative and significant relationship between transparency and procurement corruption (ß = −0.117, p < 0.008). Moreover, accountability negatively and significantly affects procurement corruption (ß = −0.162, p = 0.006). Furthermore, the findings indicate that, at a high degree of e-procurement system implementation, transparency and accountability have a stronger impact on procurement anti-corruption measures. Practical implications Policymakers and decision-makers should implement robust mechanisms that enhance transparency, accountability and anti-corruption efforts. These may include providing clear and accessible information on procurement processes, efficient mechanisms for monitoring and reporting procurement irregularities and continuous improvement of e-procurement systems. By incorporating these measures and nurturing collaboration amongst procurement stakeholders, it becomes possible to foster a procurement environment characterised by integrity, fairness, accountability and reduced corruption. Originality/value Whilst previous studies delved into exploring the effect of transparency and accountability on procurement anti-corruption, the novelty of this study is the inclusion of e-procurement as a moderating variable in the relationship between transparency, accountability and anti-corruption. By so doing, this study adds to the existing body of knowledge regarding anti-corruption measures and offers valuable practical insights for policymakers and professionals aiming to enhance transparency, accountability and ethical conduct within the public pharmaceutical procurement system.

Sustainability and high-level corruption in healthcare procurement: Profiles of Italian contracting authorities

On the role of environmental corruption in healthcare infrastructures: An empirical assessment for Italy using DEA with truncated regression approach

The extra‐legal governance of corruption: Tracing the organization of corruption in public procurement

Corruption Risk in Contracting Markets: A Network Science Perspective

The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk

Corporate social responsibility and technological perspectives in healthcare: An exploratory analysis of the evolution of the anti‐corruption system through multiple case studies

Sweeping the dirt under the rug: measuring spillovers of an anti-corruption measure

Institutions, corruption and transparency in effective healthcare public procurement: Evidence from Central and Eastern Europe

Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role?

Controlling Corruption in Development Aid: New Evidence from Contract-Level Data

Corruption and Personnel Selection and Allocation in the Public Sector

Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations

Creating value by corporate anti‐corruption models: An empirical analysis in the Italian scenario

Accountability, anti-corruption, and transparency policies in Public owned enterprises (POEs): The case of Italy

Medical Supply Acquisition in Italy and the United States in the Era of COVID-19: The Case for Strategic Procurement and Public–Private Partnerships

Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review

An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement

Differences of corruption types in selected Western and central-eastern health systems during the COVID-19 pandemic: a rapid review

Buyers' Ability in Public Procurement: A Structural Analysis of Italian Medical Devices

[What kind of training can be suitable to promote integrity within the Public Health Service? The experience of the ASL in Modena]

Understanding public procurement within the health sector: a priority in a post-COVID-19 world